View Item 
        •   Utrecht University Student Theses Repository Home
        • UU Theses Repository
        • Theses
        • View Item
        •   Utrecht University Student Theses Repository Home
        • UU Theses Repository
        • Theses
        • View Item
        JavaScript is disabled for your browser. Some features of this site may not work without it.

        Browse

        All of UU Student Theses RepositoryBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

        Digitalisation in Clinical Trials: trends in connected sensor technology use

        Thumbnail
        View/Open
        Parla Yuksel - Writing Assignment.pdf (430.1Kb)
        Publication date
        2022
        Author
        Yüksel, Parla
        Metadata
        Show full item record
        Summary
        Objective. Connected sensor technologies are remote measurement technologies that offer an objective measure of patients’ certain symptoms in their daily routine. Although there is an interest in implementing these technologies into clinical trials, adoption has been slow. Currently, there is no complete overview of connected sensor technology use for clinical drug development, analyzing the studies by the technology, year, study phase, endpoint positioning, and disease area. This overview can provide insight into the effects of different events and serve as a basis for future analysis. Methods. Studies were selected from 2 sources: the DiMe Library of Digital Endpoints and literature indexed in PubMed. Studies in DiMe Library in which product type was indicated as “drug” or “biologic” were included. A search query was developed, and the resulting articles were screened by their titles, abstracts, and text according to the inclusion criteria. Data regarding study registry year, connected sensor technology, digital clinical measure, the indication of the test drug, study phase, and endpoint positioning was extracted, and trends were compared in aggregate and over time. Results. 71 studies were identified, 63 from the DiMe library, and 8 from the literature review. Activity monitors were the most used devices (71.8%) and were the only devices observed in 2005-2014. The next most used devices were continuous glucose monitors (14.1%) and heart activity monitors (5.6%). Interest in phase 4 studies in 2015-17 was observed to shift towards phase 2 studies, the most common study phase (36.6%). More than half of the studies used connected sensor technologies to support secondary endpoints (56.3%). The most commonly addressed disease group was diseases of the nervous system (19.7%), followed by diseases of the respiratory system (18.3%), endocrine diseases (14.1%), and diseases of the circulatory system (12.8%). Most of the indicated conditions required long-term disease management. Conclusion. The use of connected sensor technologies in clinical trials was already an ongoing process for a long time. We conclude that multiple factors are contributing to increasing interest. Major factors are increased regulatory guidance and acceptance and acceleration by the COVID-19 pandemic. In the coming years, a growing interest is expected in digital measures that offer objective measurement of established endpoints, increasing the knowledge and regulatory maturity in the domain. Once the quality standards and acceptance by all the industry stakeholders are established, a steep increase in innovative digital endpoints may be observed.
        URI
        https://studenttheses.uu.nl/handle/20.500.12932/587
        Collections
        • Theses

        Related items

        Showing items related by title, author, creator and subject.

        • Abstract: The development and diffusion of clean technologies, such as heat pumps, is crucial for mitigating CO2 emissions. Technological Innovation Systems (TIS) provide a framework for understanding the diffusion and development of clean technologies in developed countries. For developing countries, however, researchers suggest an extended version of the TIS framework accounting for their characteristics of developing countries. On the top of this, researchers claim that there is a need for ex 

          Şanal, Irem (2023)
          Abstract: The development and diffusion of clean technologies, such as heat pumps, is crucial for mitigating CO2 emissions. Technological Innovation Systems (TIS) provide a framework for understanding the diffusion and ...
        • Determining offshore wind and deep geothermal technology deployment potentials in the Netherlands for the period 2010-2020. Towards a comprehensive model of deployment potentials for renewable energy technologies 

          Mackaaij, S.R.J. (2010)
          Understanding the emergence of renewable energy technologies is recently put central in research since the need to influence innovation towards more sustainable directions is high on political agendas. Where many studies ...
        • The contribution of collective action to the commercialisation of high technology: Microsystem technology in the Netherlands 

          Peters, R.A. (2012)
          In the development of new technologies, actors will pursue their private interests, but they may also try to improve the conditions for the new technology in general. This we call ‘collective action’. In this thesis, the ...
        Utrecht university logo